Notices. Notice
371 words·~2 min read·
/register/2019/12/31/2019-28249·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4164-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. FDA-2013-N-0134; FDA-2011-N-0902; FDA-2013-N-0662; FDA-2013-N-0242; FDA-2019-N-1517; FDA-2019-N-0549; FDA-2019-N-0305; FDA-2012-N-0477; FDA-2016-D-2565, and FDA-2018-N-4839] Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is publishing a list of information collections that have been approved by the Office of Management and Budget
(OMB)under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, *PRAStaff@fda.hhs.gov.* SUPPLEMENTARY INFORMATION: The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at *http://www.reginfo.gov/public/do/PRAMain.* An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Table 1—List of Information Collections Approved by OMB Title of collection OMB control No. Date approval expires Mammography Quality Standards Act Requirements 0910-0309 10/31/2022 Prescription Drug Product Labeling; Medication Guide Requirements 0910-0393 10/31/2022 Applications for FDA Approval to Market a New Drug: Patent Submission and Listing Requirements and Application of 30-month Stays on Approval of Abbreviated New Drug Applications Certifying That a Patent Claiming a Drug Is Invalid or Will Not Be Infringed 0910-0513 10/31/2022 Current Good Manufacturing Practice for Positron Emission 0910-0667 10/31/2022 Abbreviated New Animal Drug Applications 0910-0669 10/31/2022 Medical Devices: Use of Certain Symbols in Labeling—Glossary to Support the Use of Symbols in Labeling 0910-0740 10/31/2022 Deeming Tobacco Products to be Subject to the Federal Food, Drug, and Cosmetic Act 0910-0768 10/31/2022 Investigational Device Exemptions Reports and Records 0910-0078 11/30/2022 510(k) Third-Party Review Program 0910-0375 11/30/2022 Guidance for Industry With the Center for Veterinary Medicine's Electronic Submission System 0910-0454 11/30/2022 Dated: December 16, 2019. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2019-28249 Filed 12-30-19; 8:45 am]
Connectionstraces to 1
Traces to 1 document